首页> 美国卫生研究院文献>other >Impaired visual working and verbal memory in first-episode drug-naive patients with major depressive disorder in a Chinese population
【2h】

Impaired visual working and verbal memory in first-episode drug-naive patients with major depressive disorder in a Chinese population

机译:中国人群中首发初次使用药物且患有重度抑郁症的患者的视觉工作和言语记忆受损

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cognitive impairment has been observed in patients with major depressive disorder (MDD). However, it remains unclear whether the deficits in specific cognitive domains are present in first-episode, drug-naïve patients or medicated patients. In the present study, using the CogState battery (CSB) Chinese language version, we evaluated the visual, working, and verbal memory in first-episode drug-naive patients and medicated patients with MDD in a Chinese population. We measured the cognitive function in first-episode drug-naïve patients (n = 36), medicated MDD patients (n = 71), and age- and sex-matched healthy control subjects (n = 59) in a Chinese population. The CSB composite scores in both first-episode drug-naive patients and medicated patients were significantly poorer than those in the healthy control subjects. The CSB sub-scores, including visual, working, and verbal memory were also significantly poorer in both patient groups than those in the healthy control subjects. In contrast, processing speed, attention/vigilance, executive function, spatial working memory, and social cognition were no different from healthy controls, whereas the executive function was significantly better in the medicated patients than in the healthy control subjects and first-episode drug-naïve patients. These findings suggest an impairment in the visual, working, and verbal memory in first-episode, drug-naive MDD patients in a Chinese population.
机译:在重度抑郁症(MDD)患者中已观察到认知障碍。然而,目前尚不清楚在首发,未接受过药物治疗的患者或在用药的患者中是否存在特定认知领域的缺陷。在本研究中,我们使用中文版的CogState电池(CSB),评估了中国人群中首发未使用过药物的患者和MDD药物治疗患者的视觉,工作和言语记忆。我们测量了中国人群中首次未接受过药物治疗的患者(n = 36),药物治疗的MDD患者(n = 71)以及年龄和性别相匹配的健康对照组(n = 59)的认知功能。首次接受药物治疗的初次接受治疗的患者和接受药物治疗的患者的CSB综合评分均明显低于健康对照组的CSB综合评分。在两个患者组中,包括视觉,工作和言语记忆在内的CSB子评分也显着低于健康对照组。相比之下,处理速度,注意力/警惕性,执行功能,空间工作记忆和社交认知与健康对照组无差异,而加药患者的执行功能明显好于健康对照组和首发药物治疗组。天真的病人。这些发现表明,中国人群中首发,未使用过药物的MDD患者的视觉,工作和言语记忆均受到损害。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号